Imiquimod for the treatment of oral leukoplakia: A two-center retrospective study.
Hervé Y SroussiAlessandro VillaMalak Adel AlhadlaqKentaro IkedaSivappiriyai VeluppillaiNathaniel TreisterAnette Vistoso MonrealPiamkamon VacharotayangulMichele LodoloSook-Bin WooPublished in: Oral diseases (2024)
Two-thirds of OL lesions had ≥50% reduction in size. Most AEs were temporary and resolved upon treatment discontinuation. Prospective studies are needed to further assess Imiquimod's effectiveness in OL management.